Former EVP, Chief Financial Officer and Treasurer · NOVAVAX INC (NVAX)

Gregory Covino

FY2020 is the first fiscal year CompBrief holds for Gregory Covino as a named executive officer of NOVAVAX; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,417,774

Salary $55,000Stock awards $661,745

5th of 5 named executive officers at Novavax by FY2020 total.

5 named officers on file for NOVAVAX, FY2020

Gregory Covino’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • NVAX’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NOVAVAX’s whole pay program stands against its peers

  • NOVAVAX’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NVAX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 3, 2021 (DEF 14A).

Free

Get Gregory Covino’s full pay file as a PDF — free

More than this page: up to 10 years of Gregory’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Gregory Covino compensation by year

NOVAVAX Summary Compensation Table · the one fiscal year held
In US dollars, as NOVAVAX reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$55,000
Bonus$0
Stock awards$661,745
Option awards$659,967
Non-equity incentive$33,000
Pension and deferred compensation$0
All other$8,032
Total$1,417,774

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NOVAVAX INC DEF 14A filed May 3, 2021, accession 0001104659-21-060332, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NOVAVAX INC filed document, accession 0001104659-21-060332. Every figure is read from that document and cited to the page and table it appears in. Filed May 3, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU7,300$661,745—
Option8,200—$90.65

Per the Outstanding Equity Awards at Fiscal Year-End table in NOVAVAX INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

NOVAVAX’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Stanley ErckPresident and CEO$48,086,018
Gregory GlennPresident, Research and Development$24,923,376
John TrizzinoEVP, Chief Commercial Officer, Chief Business Officer and Interim Chief Financial Officer$21,327,954
John HerrmannEVP, Chief Legal Officer and Corporate Secretary$20,606,814
Gregory Covino · this pageFormer EVP, Chief Financial Officer and Treasurer$1,417,774

The full NOVAVAX compensation record

free company brief

This page is one person within NOVAVAX's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NOVAVAX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Gregory Covino's compensation dossier · One-time report. No refunds.